Tot Bui

905 total citations
30 papers, 749 citations indexed

About

Tot Bui is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, Tot Bui has authored 30 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Virology and 9 papers in Oncology. Recurrent topics in Tot Bui's work include HIV Research and Treatment (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and HIV/AIDS drug development and treatment (9 papers). Tot Bui is often cited by papers focused on HIV Research and Treatment (11 papers), Drug Transport and Resistance Mechanisms (9 papers) and HIV/AIDS drug development and treatment (9 papers). Tot Bui collaborates with scholars based in United States, France and Switzerland. Tot Bui's co-authors include Rodney J. Y. Ho, Ziping Yang, Noha N. Salama, Danny D. Shen, Erica L. Woodahl, Jashvant D. Unadkat, Connie R. Faltynek, Peng Hsiao, William R. Morton and Kay Larsen and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Tot Bui

29 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tot Bui United States 15 328 199 186 174 164 30 749
J. H. Beijnen Netherlands 17 295 0.9× 100 0.5× 43 0.2× 320 1.8× 73 0.4× 40 797
Muhammad Baluom United States 17 101 0.3× 91 0.5× 61 0.3× 116 0.7× 24 0.1× 20 781
Sarah Allegra Italy 16 119 0.4× 248 1.2× 88 0.5× 131 0.8× 37 0.2× 59 801
D. Farquhar United States 14 91 0.3× 167 0.8× 29 0.2× 258 1.5× 108 0.7× 37 629
Masashi Uchida Japan 13 146 0.4× 53 0.3× 43 0.2× 150 0.9× 21 0.1× 44 543
Danielle N McLennan Australia 10 97 0.3× 80 0.4× 38 0.2× 237 1.4× 17 0.1× 11 656
F. Albano Italy 17 102 0.3× 149 0.7× 17 0.1× 302 1.7× 62 0.4× 44 705
JH Beijnen Netherlands 11 132 0.4× 91 0.5× 38 0.2× 78 0.4× 63 0.4× 15 364
Dwaipayan Mukherjee United States 11 126 0.4× 55 0.3× 68 0.4× 339 1.9× 13 0.1× 30 708
Enrica Alteri Switzerland 13 75 0.2× 94 0.5× 19 0.1× 97 0.6× 109 0.7× 21 602

Countries citing papers authored by Tot Bui

Since Specialization
Citations

This map shows the geographic impact of Tot Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tot Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tot Bui more than expected).

Fields of papers citing papers by Tot Bui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tot Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tot Bui. The network helps show where Tot Bui may publish in the future.

Co-authorship network of co-authors of Tot Bui

This figure shows the co-authorship network connecting the top 25 collaborators of Tot Bui. A scholar is included among the top collaborators of Tot Bui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tot Bui. Tot Bui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bui, Tot, et al.. (2010). Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging. PLoS ONE. 5(9). e13082–e13082. 46 indexed citations
3.
Woodahl, Erica L., Matthew H. Crouthamel, Tot Bui, Danny D. Shen, & Rodney J. Y. Ho. (2009). MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents. Cancer Chemotherapy and Pharmacology. 64(1). 183–188. 30 indexed citations
4.
Yang, Ziping, Daniel Wu, Tot Bui, & Rodney J. Y. Ho. (2008). A Novel Human Multidrug Resistance Gene MDR1 Variant G571A (G191R) Modulates Cancer Drug Resistance and Efflux Transport. Journal of Pharmacology and Experimental Therapeutics. 327(2). 474–481. 24 indexed citations
5.
Hsiao, Peng, Tot Bui, Rodney J. Y. Ho, & Jashvant D. Unadkat. (2007). In Vitro-to-in Vivo Prediction of P-glycoprotein-Based Drug Interactions at the Human and Rodent Blood-Brain Barrier. Drug Metabolism and Disposition. 36(3). 481–484. 53 indexed citations
6.
Bui, Tot, et al.. (2007). pH-Dependent Interactions of Indinavir and Lipids in Nanoparticles and Their Ability to Entrap a Solute. Journal of Pharmaceutical Sciences. 97(2). 931–943. 32 indexed citations
7.
Salama, Noha N., Ziping Yang, Tot Bui, & Rodney J. Y. Ho. (2006). MDR1 haplotypes significantly minimize intracellular uptake and transcellular P‐gp substrate transport in recombinant LLC‐PK1 cells. Journal of Pharmaceutical Sciences. 95(10). 2293–2308. 145 indexed citations
8.
Woodahl, Erica L., Ziping Yang, Tot Bui, Danny D. Shen, & Rodney J. Y. Ho. (2005). MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells. AIDS. 19(15). 1617–1625. 48 indexed citations
9.
Salama, Noha N., Edward J. Kelly, Tot Bui, & Rodney J. Y. Ho. (2005). The Impact of Pharmacologic and Genetic Knockout of P-Glycoprotein on Nelfinavir Levels in the Brain and Other Tissues in Mice. Journal of Pharmaceutical Sciences. 94(6). 1216–1225. 32 indexed citations
10.
Woodahl, Erica L., Ziping Yang, Tot Bui, Danny D. Shen, & Rodney J. Y. Ho. (2004). Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-Glycoprotein. Journal of Pharmacology and Experimental Therapeutics. 310(3). 1199–1207. 61 indexed citations
11.
Graves, Scott S., et al.. (2003). Analysis of Coenzyme Q<SUB>10</SUB> Content in Human Plasma and Other Biological Samples. Humana Press eBooks. 108. 353–365. 10 indexed citations
12.
Brodie, Scott J., Tot Bui, Kay Larsen, et al.. (2003). Lipid–Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(4). 387–397. 71 indexed citations
13.
Yang, Zihuan, et al.. (2002). Semi-Quantitative RT-PCR Method to Estimate Full-Length mRNA Levels of the Multidrug Resistance Gene. BioTechniques. 33(1). 196–203. 13 indexed citations
14.
Ho, Rodney J. Y., Kay Larsen, Tot Bui, et al.. (2000). Suppression of Maternal Virus Load With Zidovudine, Didanosine, and Indinavir Combination Therapy Prevents Mother-to-Fetus HIV Transmission in Macaques. JAIDS Journal of Acquired Immune Deficiency Syndromes. 25(2). 140–149. 4 indexed citations
15.
Lian, Tianshun, Tot Bui, & Rodney J. Y. Ho. (1999). Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses. Vaccine. 18(7-8). 604–611. 16 indexed citations
16.
17.
Bethune, Claudette, et al.. (1997). Development of a high-performance liquid chromatographic assay for G418 sulfate (Geneticin). Antimicrobial Agents and Chemotherapy. 41(3). 661–664. 2 indexed citations
18.
Bui, Tot, Connie R. Faltynek, & Rodney J. Y. Ho. (1994). Biological response of recombinant interleukin-7 on herpes simplex virus infection in guinea-pigs. Vaccine. 12(7). 646–652. 9 indexed citations
19.
Qian, Mingxin, Tot Bui, Rodney J. Y. Ho, & Jashvant D. Unadkat. (1994). Metabolism of 3′-azido-3′-deoxythymidine (AZT) in human placentae trophoblasts and Hofbauer cells. Biochemical Pharmacology. 48(2). 383–389. 36 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. H. Beijnen Breakdown of academic impact, for papers by Muhammad Baluom Breakdown of academic impact, for papers by Sarah Allegra Breakdown of academic impact, for papers by D. Farquhar Breakdown of academic impact, for papers by Masashi Uchida Breakdown of academic impact, for papers by Danielle N McLennan Breakdown of academic impact, for papers by F. Albano Breakdown of academic impact, for papers by JH Beijnen Breakdown of academic impact, for papers by Dwaipayan Mukherjee Breakdown of academic impact, for papers by Enrica Alteri
Rankless by CCL
2026